This dangerous combo in your body could raise death risk by 83%
Having both excess belly fat and low muscle mass isn’t just unhealthy—it’s potentially deadly, raising the risk of death by 83%. This condition, called sarcopenic obesity, creates a vicious cycle where fat accelerates muscle breakdown and...
schedule
05:23 visibility
199 views
Source: Science Daily
Having both excess belly fat and low muscle mass isn’t just unhealthy—it’s potentially deadly, raising the risk of death by 83%. This condition, called sarcopenic obesity, creates a vicious cycle where fat accelerates muscle breakdown and inflammation. Researchers found it can be identified using simple measurements, not costly medical tests. That means earlier detection—and a real chance to intervene before serious decline sets in.
German company Isar Aerospace has successfully launched Europe's first entirely commercial orbital rocket. It attempted to achieve the feat last March, but that lasted all of 30 seconds before the vehicle crashed into the sea and exploded. This time...
German company Isar Aerospace has placed its Spectrum rocket in low Earth orbit at the second attempt, becoming the first European firm to do so with its own launcher and hitting the first milestone of ESA's European Launcher Challenge.
German firm Isar Aerospace has placed its Spectrum rocket into low Earth orbit on its second attempt, becoming the first European company to do so with its own launcher and hitting the first milestone in ESA's European Launcher Challenge.
Основанный 8 лет назад баварский стартап Isar Aerospace запустил в космос ракету Spectrum в ходе ее второго испытания. Она стартовала с норвежского космодрома Аннёйя. Это значительный шаг для космической отрасли Европы.
GoPro CEO Nick Woodman said in a letter to customers that making cameras is still his company's "core DNA," after a proposed $285 million acquisition by Starman was announced earlier this week. He claims the merger puts GoPro in a better position to...
Research published in the journal Science illuminates a "missing piece" in the biological understanding of profound autism and offers new targets for drug development.
NPR News
We use cookies to improve your experience. By continuing to use this site, you agree to our use of cookies. Learn more